Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franz J Hilke

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Bioinformatics (Oxford, England)|January 29, 2017
A comprehensive quality control workflow for paired tumor-normal NGS experimentsChristopher M Schroeder, Franz J Hilke, Markus W Löffler, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 12, 2018
Circulating cell-free DNA: A potential biomarker to differentiate inflammation and infection during radiochemotherapyKerstin Zwirner, Franz J Hilke, German Demidov, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 21, 2020
Dynamics of cell-free tumour DNA correlate with treatment response of head and neck cancer patients receiving radiochemotherapyFranz J Hilke, Francesc Muyas, Jakob Admard, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 25, 2019
Radiogenomics in head and neck cancer: correlation of radiomic heterogeneity and somatic mutations in TP53, FAT1 and KMT2DKerstin Zwirner, Franz J Hilke, German Demidov, et al.
Cancers|August 23, 2020
Distinct Mutation Patterns Reveal Melanoma Subtypes and Influence Immunotherapy Response in Advanced Melanoma PatientsFranz J Hilke, Tobias Sinnberg, Axel Gschwind, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 27, 2020
PET/MRI and genetic intrapatient heterogeneity in head and neck cancersKerstin Clasen, Sara Leibfarth, Franz J Hilke, et al.
Cancers|December 23, 2020
Clinical and Genetic Tumor Characteristics of Responding and Non-Responding Patients to PD-1 Inhibition in Hepatocellular CarcinomaStephan Spahn, Daniel Roessler, Radu Pompilia, et al.
BMC Medical Genetics|August 17, 2018
First case report of malignant peritoneal mesothelioma and oral verrucous carcinoma in a patient with a germline PTEN mutation: a combination of extremely rare diseases with probable further implicationsMarkus W Löffler, Julia Steinhilber, Franz J Hilke, et al.
European Journal of Cancer (Oxford, England : 1990)|August 13, 2021
A benchmark for neural network robustness in skin cancer classificationRoman C Maron, Justin G Schlager, Sarah Haggenmüller, et al.
Communications Medicine|September 10, 2024
Prospective multicenter study using artificial intelligence to improve dermoscopic melanoma diagnosis in patient careLukas Heinlein, Roman C Maron, Achim Hekler, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Bioinformatics (Oxford, England)|January 29, 2017
A comprehensive quality control workflow for paired tumor-normal NGS experimentsChristopher M Schroeder, Franz J Hilke, Markus W Löffler, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 12, 2018
Circulating cell-free DNA: A potential biomarker to differentiate inflammation and infection during radiochemotherapyKerstin Zwirner, Franz J Hilke, German Demidov, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 21, 2020
Dynamics of cell-free tumour DNA correlate with treatment response of head and neck cancer patients receiving radiochemotherapyFranz J Hilke, Francesc Muyas, Jakob Admard, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 25, 2019
Radiogenomics in head and neck cancer: correlation of radiomic heterogeneity and somatic mutations in TP53, FAT1 and KMT2DKerstin Zwirner, Franz J Hilke, German Demidov, et al.
Cancers|August 23, 2020
Distinct Mutation Patterns Reveal Melanoma Subtypes and Influence Immunotherapy Response in Advanced Melanoma PatientsFranz J Hilke, Tobias Sinnberg, Axel Gschwind, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 27, 2020
PET/MRI and genetic intrapatient heterogeneity in head and neck cancersKerstin Clasen, Sara Leibfarth, Franz J Hilke, et al.
Cancers|December 23, 2020
Clinical and Genetic Tumor Characteristics of Responding and Non-Responding Patients to PD-1 Inhibition in Hepatocellular CarcinomaStephan Spahn, Daniel Roessler, Radu Pompilia, et al.
BMC Medical Genetics|August 17, 2018
First case report of malignant peritoneal mesothelioma and oral verrucous carcinoma in a patient with a germline PTEN mutation: a combination of extremely rare diseases with probable further implicationsMarkus W Löffler, Julia Steinhilber, Franz J Hilke, et al.
European Journal of Cancer (Oxford, England : 1990)|August 13, 2021
A benchmark for neural network robustness in skin cancer classificationRoman C Maron, Justin G Schlager, Sarah Haggenmüller, et al.
Communications Medicine|September 10, 2024
Prospective multicenter study using artificial intelligence to improve dermoscopic melanoma diagnosis in patient careLukas Heinlein, Roman C Maron, Achim Hekler, et al.
Pageof 2